Patents Assigned to CIBIEM, INC.
-
Patent number: 10219855Abstract: Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.Type: GrantFiled: August 15, 2017Date of Patent: March 5, 2019Assignee: Cibiem, Inc.Inventors: Mark Gelfand, Howard Levin
-
Patent number: 9955946Abstract: Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation.Type: GrantFiled: March 12, 2015Date of Patent: May 1, 2018Assignee: Cibiem, Inc.Inventors: Jason Michael Miller, Yegor D. Sinelnikov, Zoar Jacob Engelman, Martin M. Grasse, Michael Brick Markham, Veijo T. Suorsa, Miriam H. Taimisto
-
Patent number: 9808303Abstract: Methods and cryogenic devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. Some methods include advancing a cryo-ablation catheter into a patient's vasculature and ablating tissue within a carotid septum.Type: GrantFiled: August 2, 2016Date of Patent: November 7, 2017Assignee: Cibiem, Inc.Inventors: Eric Ryba, Mark Gelfand
-
Patent number: 9795784Abstract: Systems and methods for treating a patient with dyspnea are disclosed. A method in accordance with a particular embodiment includes identifying the patient as suffering from dyspnea, and, based at least in part on identifying the patient as suffering from dyspnea, implanting an electrical signal delivery element within the patient in signal communication with an afferent neural pathway of a carotid body chemoreceptor. The method can further include at least reducing dyspneic sensations in the patient by directing an electrical signal from the electrical signal delivery element to the neural pathway to at least partially block afferent signals from the chemoreceptor.Type: GrantFiled: September 6, 2016Date of Patent: October 24, 2017Assignee: Cibiem, Inc.Inventors: Edwin J. Hlavka, Lynn S. Elliott
-
Patent number: 9757180Abstract: Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.Type: GrantFiled: July 19, 2016Date of Patent: September 12, 2017Assignee: Cibiem, Inc.Inventors: Mark Gelfand, Howard Levin, Charles Lennox
-
Patent number: 9433784Abstract: Systems and methods for treating a patient with dyspnea are disclosed. A method in accordance with a particular embodiment includes identifying the patient as suffering from dyspnea, and, based at least in part on identifying the patient as suffering from dyspnea, implanting an electrical signal delivery element within the patient in signal communication with an afferent neural pathway of a carotid body chemoreceptor. The method can further include at least reducing dyspneic sensations in the patient by directing an electrical signal from the electrical signal delivery element to the neural pathway to at least partially block afferent signals from the chemoreceptor.Type: GrantFiled: July 28, 2015Date of Patent: September 6, 2016Assignee: CIBIEM, INC.Inventors: Edwin J. Hlavka, Lynn S. Elliott
-
Patent number: 9402677Abstract: Methods and cryogenic devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. Some methods include advancing a cryo-ablation catheter into a patient's vasculature and ablating tissue within a carotid septum.Type: GrantFiled: June 3, 2013Date of Patent: August 2, 2016Assignee: CIBIEM, INC.Inventors: Mark S. Leung, Zoar Jacob Engelman, Martin M. Grasse, Mark Gelfand, Howard Levin
-
Patent number: 9398930Abstract: Methods and percutaneous devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via percutaneous carotid body ablation.Type: GrantFiled: June 3, 2013Date of Patent: July 26, 2016Assignee: CIBIEM, INC.Inventors: Mark Leung, Brett Schleicher, Charles Lennox, Ary Chernomorsky, Zoar Jacob Engelman, Marat Fudim, Martin M. Grasse, Mark Gelfand, Howard Levin
-
Patent number: 9393070Abstract: Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor.Type: GrantFiled: April 24, 2013Date of Patent: July 19, 2016Assignee: CIBIEM, INC.Inventors: Mark Gelfand, Howard Levin, Charles Lennox, Marat Fudim, Zoar Jacob Engelman, Martin M. Grasse, Brett Schleicher
-
Patent number: 9283033Abstract: Methods and devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation.Type: GrantFiled: July 1, 2013Date of Patent: March 15, 2016Assignee: CIBIEM, INC.Inventors: Mark Gelfand, Charles Lennox, Ary Chernomorsky, Howard Levin, Veijo T. Suorsa, Kenneth M. Martin, Yegor D. Sinelnikov
-
Patent number: 9089700Abstract: Systems and methods for treating a patient with dyspnea are disclosed. A method in accordance with a particular embodiment includes identifying the patient as suffering from dyspnea, and, based at least in part on identifying the patient as suffering from dyspnea, implanting an electrical signal delivery element within the patient in signal communication with an afferent neural pathway of a carotid body chemoreceptor. The method can further include at least reducing dyspneic sensations in the patient by directing an electrical signal from the electrical signal delivery element to the neural pathway to at least partially block afferent signals from the chemoreceptor.Type: GrantFiled: August 7, 2009Date of Patent: July 28, 2015Assignee: CIBIEM, INC.Inventors: Edwin J. Hlavka, Lynn S. Elliott